Antimicrobial Drug Resistance of Vibrio cholerae, Democratic Republic of the Congo
Berthe Miwanda, Sandra Moore, Jean-Jacques Muyembe, Georges Nguefack-Tsague, Ickel Kakongo Kabangwa, Daniel Yassa Ndjakani, Ankur Mutreja, Nicholas R. Thomson, Helene Thefenne, Eric Garnotel, Gaston Tshapenda, Denis Kandolo Kakongo, Guy Kalambayi, and Renaud Piarroux
Author affiliations: Ministry of Public Health, Kinshasa, Democratic Republic of the Congo (B. Miwanda, J.-J. Muyembe, G. Tshapenda); Aix-Marseille University, Marseille, France (S. Moore, R. Piarroux); University of Kinshasa, Kinshasa (J.-J. Muyembe); University of Yaoundé I, Yaoundé, Cameroon (G. Nguefack-Tsague); Ministry of Higher Education and University, Kinshasa (I.K. Kabangwa, D.K. Kakongo); Field Epidemiology Laboratory Training Program, Kinshasa (D.Y. Ndjakani); Wellcome Trust Sanger Institute, Cambridge, UK (A. Mutreja, N. Thomson); London School of Hygiene and Tropical Medicine, London, UK (N. Thomson); Hôpital d’Instruction des Armées Laveran, Marseille, France (H. Thefenne, E. Garnotel); World Health Organization, Ouagadougou, Burkina Faso (D.K. Kakongo); World Health Organization, Kinshasa (G. Kalambayi)
Figure 1. Vibrio cholerae strain antimicrobial drug resistance profiles plotted by year, Democratic Republic of the Congo, 1997–2012. On the basis of the antibiogram results, strains were grouped into 21 antimicrobial drug resistance profiles. The antimicrobial drugs to which the strains displayed resistance are indicated on the right. Circle circumference represents the relative number of isolates per profile. AM, ampicillin; C, chloramphenicol; SXT, sulfamethoxazole/trimethoprim; TE, tetracycline; DO, doxycycline; NOR, norfloxacin; CI, ciprofloxacin; NA, nalidixic acid; E, erythromycin.
Page created: April 17, 2015
Page updated: April 17, 2015
Page reviewed: April 17, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.